Prostaglandin E2 Receptor, EP3, Is Induced in Diabetic Islets and Negatively Regulates Glucose- and Hormone-Stimulated Insulin Secretion
Open Access
- 20 May 2013
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 62 (6), 1904-1912
- https://doi.org/10.2337/db12-0769
Abstract
BTBR mice develop severe diabetes in response to genetically induced obesity due to a failure of the β-cells to compensate for peripheral insulin resistance. In analyzing BTBR islet gene expression patterns, we observed that Pgter3, the gene for the prostaglandin E receptor 3 (EP3), was upregulated with diabetes. The EP3 receptor is stimulated by prostaglandin E2 (PGE2) and couples to G-proteins of the Gi subfamily to decrease intracellular cAMP, blunting glucose-stimulated insulin secretion (GSIS). Also upregulated were several genes involved in the synthesis of PGE2. We hypothesized that increased signaling through EP3 might be coincident with the development of diabetes and contribute to β-cell dysfunction. We confirmed that the PGE2-to-EP3 signaling pathway was active in islets from confirmed diabetic BTBR mice and human cadaveric donors, with increased EP3 expression, PGE2 production, and function of EP3 agonists and antagonists to modulate cAMP production and GSIS. We also analyzed the impact of EP3 receptor activation on signaling through the glucagon-like peptide (GLP)-1 receptor. We demonstrated that EP3 agonists antagonize GLP-1 signaling, decreasing the maximal effect that GLP-1 can elicit on cAMP production and GSIS. Taken together, our results identify EP3 as a new therapeutic target for β-cell dysfunction in T2D.Keywords
This publication has 49 references indexed in Scilit:
- Deletion of GαZ Protein Protects against Diet-induced Glucose Intolerance via Expansion of β-Cell MassPublished by Elsevier BV ,2012
- Positional Cloning of a Type 2 Diabetes Quantitative Trait Locus; Tomosyn-2, a Negative Regulator of Insulin SecretionPLoS Genetics, 2011
- FoxM1 Is Up-Regulated by Obesity and Stimulates β-Cell ProliferationMolecular Endocrinology, 2010
- Mechanisms of biphasic insulin-granule exocytosis – roles of the cytoskeleton, small GTPases and SNARE proteinsJournal of Cell Science, 2009
- Mouse EP3 α, β, and γ Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis in VivoJournal of Biological Chemistry, 2008
- A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibilityGenome Research, 2008
- Mechanisms of action of glucagon-like peptide 1 in the pancreasPharmacology & Therapeutics, 2007
- Night eating and obesity in the EP3R-deficient mouseProceedings of the National Academy of Sciences of the United States of America, 2007
- Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitusDiabetologia, 2006
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995